Please use this identifier to cite or link to this item:
Title: Drug interaction between acetyltanshinone IIA and rapamycin in breast cancer cells
Authors: Wong, De Pin
Keywords: DRNTU::Engineering::Bioengineering
Issue Date: 2014
Abstract: Combination drug therapy is most widely used in breast cancer treatment. One of the key benefits of drug combination is the effect of synergism which provides mutual enhancement to the therapeutic effect. Developing in vitro drug combination study is essential for the development of new and effective combination regimens. In this project, the objective is to investigate the synergistic potential between two anti breast cancer agent, rapamycin and acetyltanshinone IIA (ATA) in breast cancer cells. MTT assay was performed to test for the growth inhibitory effect of individual drugs and their combinations. Drug combination studies for both non fixed and fixed constant ratio (1:6400) were conducted. Median drug effect analysis was performed using the software CompuSyn to determine the combination index value and the synergism between the drugs. Result indicated that drug combination between rapamycin and ATA resulted in increase in growth inhibitory effect in both non fixed and fixed constant ratio studies. Median drug effect analysis showed that there is strong level of synergism between rapamycin and ATA.
Rights: Nanyang Technological University
Fulltext Permission: restricted
Fulltext Availability: With Fulltext
Appears in Collections:SCBE Student Reports (FYP/IA/PA/PI)

Files in This Item:
File Description SizeFormat 
Wong De Pin FYP final softcopy.docx
  Restricted Access
733.06 kBMicrosoft WordView/Open

Page view(s) 10

checked on Oct 25, 2020

Download(s) 10

checked on Oct 25, 2020

Google ScholarTM


Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.